New Hampshire Life Members and co-sponsoring Boston Life Members
CRISPR/Cas9 and related protein: RNA complexes are Gene Editing enzymes that are revolutionizing biological research and also starting to enter the therapeutic realm. A Cas9-based therapeutic strategy to treat sickle cell anemia received approval recently in the United Kingdom and is also being considered for FDA approval in the United States.
In this presentation, I will give a broad introduction to enzymes used for Gene Editing, including Cas9, base editors, and prime editors. This introduction is intended for both non-biologists and biologists, including the role of computational analysis in understanding gene editing outcomes.
Dr. Vikram (MD/PhD Harvard University) is the Director of Histocompatibility (HLA) Laboratory at the Massachusetts General Hospital and an Instructor in Pathology, Harvard Medical School
You can learn more about his background and contributions through the following links.
Mass General: https://www.massgeneral.org/doctors/20264/vikram-pattanayak
Google Scholar: https://scholar.google.com/citations?user=jlc25hYAAAAJ&hl=en